Advertisement

Topics

Tilak Announces CE Marking for Odysight, Its First Mobile Medical Game in Ophthalmology

05:00 EDT 14 Jun 2018 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Launching of the Beta-testing phase in France and in the United Kingdom Tilak, a company from the iBionext network developing mobile medical applications for the management of chronic diseases, announced that Odysight...

Other Sources for this Article

Tilak
Edouard Gasser - +33 (0) 7 62 27 18 42
egasser@tilakhealthcare.com
or
Media
NewCap
Annie-Florence Loyer
+33 (0)1 44 71 00 12 / +33 (0)6 88 20 35 59
afloyer@newcap.fr
or
Léa Jacquin, +33 (0)1 44 71 20 41
ljacquin@newcap.fr

NEXT ARTICLE

More From BioPortfolio on "Tilak Announces CE Marking for Odysight, Its First Mobile Medical Game in Ophthalmology"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...